Beck Bode LLC’s Evolus EOLS Stock Holding History

Beck Bode LLC’s Portfolio EOLS Stock Details EOLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-163	Closed	-$1K	–	98
2020 Q3	$1K	Buy	+163	New	+$595	﹤0.01%	297

Other funds holding EOLS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

ECM

ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return

AWH Capital Dallas, Texas $146M AUM 71.66% 1-Year Est. Return

Beck Bode LLC's EOLS Position: Q4 2020 in Review

Beck Bode LLC sold out of Evolus (EOLS) in Q4 2020, closing a stake of 163 shares — an estimated $1K sold.

Beck Bode LLC first reported a position in EOLS in Q3 2020 and held it in 1 quarter. The position peaked at $1K in Q3 2020. 85 funds tracked by Wall St. Rank hold EOLS as of Q4 2020.

Beck Bode LLC reported no remaining Evolus position as of Q4 2020 after selling out during the quarter.
Beck Bode LLC sold 163 Evolus shares in Q4 2020, an estimated $1K.
Beck Bode LLC first reported a position in Evolus in Q3 2020 and held it in 1 quarter.
Beck Bode LLC's Evolus position peaked at $1K in Q3 2020.
85 funds tracked by Wall St. Rank held Evolus as of Q4 2020.

Based on Beck Bode LLC's 13F filing for Q4 2020.